Sleep and psychological disorders seriously affect the quality of life of chronic rhinosinusitis patients.

PURPOSE: Chronic rhinosinusitis (CRS) is a common disease that affects patients' quality of life (QoL). We aim to explore which symptoms bothered the patient most. METHODS: This is a cross-sectional study of CRS patients 2 years after endoscopic sinus surgery (ESS). The main observation indicators were SNOT-22 and visual analog scale (VAS) scores. The patients were grouped according to clinical control standard of EPOS 2020. Patients' symptom scores and postoperative medication were used for analysis. RESULTS: A total of 276 patients were included, among them, uncontrolled patients accounted for 23.9%, sense of taste/smell, fatigue, lacking of a good night's sleep, reduced concentration and reduced productivity were the most serious symptoms that troubled them. VAS and SNOT-22 scores were significantly different among all groups (P = 0.000), and had clinical significance for the diagnosis of clinical uncontrolled patients (both P < 0.0001). Furthermore, the duration of corticosteroids use and nasal saline irrigation in uncontrolled patients was significantly longer than that in other patients (P < 0.05). CONCLUSION: There are significant differences in the QoL of CRS patients with different clinical control, sleep and psychological disorders are main symptoms that affect the QoL of CRS patients, and more targeted management of sleep/psychological issues may be needed especially for uncontrolled patients.

Rational Design of Reversible Redox Shuttle for Highly Efficient Light-Driven Microswimmer.

The light-driven micro/nanomotor (LMNM) is machinery that harvests photon energy and generates self-propulsion in varieties of liquid media. Though visions are made that these tiny swimming machines can serve future medicine for accurate drug delivery and noninvasive microsurgery, their biomedical application is still impeded by the insufficient propulsion efficiency. Here we provide a holistic model of LMNM by considering (i) photovoltaic, (ii) electrochemical, and (iii) electrokinetic processes therein. Such a quantitative model revealed the pivotal role of reaction kinetics and diffusion properties of shuttle ions in the propulsion efficiency of LMNM. With the guidance of this model, a group of ferrocene-based reversible redox shuttles, which generate slow-diffusion ions, was identified, showcasing a high locomotion velocity of ∼500 µm/s (∼100 body length per second) at an ultralow concentration (70 µM). Owing to the in-depth understanding of the fundamental energy conversion processes in LMNM, we anticipate that the development of other high-performance supporting chemicals and LMNM systems will be greatly motivated, foreseeing the advent of LMNM systems with superior efficiency.

A review of EPAP nasal device therapy for obstructive sleep apnea syndrome.

BACKGROUND: Expiratory positive airway pressure (EPAP) nasal devices provide a new therapeutic option for obstructive sleep apnea (OSA). METHODS: Here, we review the literature about treatment of OSA with EPAP, which has been shown to reduce the apnea/hypopnea index (AHI) and daytime sleepiness. RESULTS: Patients generally prefer EPAP to continuous positive airway pressure (CPAP), and there are no serious adverse effects from its use. Although CPAP more effectively improves sleep apnea, a recent study showed similar outcomes in symptom improvement using EPAP. Patients with mild to moderate OSA who do not tolerate CPAP are appropriate candidates for EPAP. However, there are few well-designed clinical trials that evaluate efficacy. CONCLUSIONS: More studies are needed to assess the efficacy of and compliance with EPAP nasal devices, to define which patients will benefit from EPAP therapy, and to compare EPAP to other alternative OSA therapies.